Introduction {#s1}
============

*Coxiella burnetii* is a highly infectious human pathogen responsible for a global zoonotic disease called Q fever. Inhalation of contaminated aerosols by humans can lead to an acute systemic illness or a more serious chronic infection that commonly presents as endocarditis [@ppat.1004286-Maurin1], [@ppat.1004286-vanderHoek1]. The animal reservoirs for *C. burnetii* include domesticated livestock, and transmission to humans from these animals can lead to outbreaks of disease, such as the Q-fever epidemic that was linked to dairy goat farms in the Netherlands [@ppat.1004286-vanderHoek1].

Phase I strains of *C. burnetii* produce a lipopolysaccharide molecule that has a complex O-antigen polysaccharide chain that protects the bacteria from being killed by host serum [@ppat.1004286-Moos1]. Phase II variants of *C. burnetii* produce a truncated O-antigen polysaccharide and can be isolated from both infected animals and bacteria cultured *ex vivo* [@ppat.1004286-Moos1], [@ppat.1004286-Hoover1]. Although most strains of *C. burnetii* exhibit phase variation and switch between phase I and phase II spontaneously, a phase II variant of the *C. burnetii* Nine Mile strain RSA493 called clone 4 (NMII) is phase locked because it has a chromosomal deletion that eliminates several genes required for the synthesis of O-antigen polysaccharide, which makes this strain incapable of causing systemic disease in guinea pig and mouse models of infection and enhances innate immune detection [@ppat.1004286-Moos1], [@ppat.1004286-Hoover1]. Nonetheless, it has been shown that the NMII strain is indistinguishable from the isogenic phase I strain (NMI) in tissue culture models of infection that measure the ability of *C. burnetii* to replicate in human cells, which include studies in primary human monocyte-derived macrophages [@ppat.1004286-Howe1], [@ppat.1004286-Baca1]. Importantly, NMI and NMII encode the same array of virulence determinants that have evolved for manipulating cellular functions important for intracellular replication.

Intracellular replication of *C. burnetii* requires formation of a specialized membrane-bound compartment termed the *Coxiella*-containing vacuole (CCV). After cells internalize *C. burnetii* there is host-directed transport of the CCV through the endocytic pathway, which delivers the bacteria to the low pH environment of a lysosome [@ppat.1004286-vanSchaik1], [@ppat.1004286-McDonough1]. Intracellular *C. burnetii* resist the hydrolytic and bactericidal activities inside the lysosome and the acidic pH of this organelle is required to stimulate *C. burnetii* metabolism, which enables the bacteria to survive and replicate intracellularly [@ppat.1004286-Hackstadt1], [@ppat.1004286-Coleman1]. Although the molecular mechanisms used by *C. burnetii* to transform a lysosome into a replication-permissive compartment remain unclear, there is evidence that this compartment interacts with vesicles derived from the host autophagic and secretory pathways [@ppat.1004286-Campoy1]--[@ppat.1004286-Gutierrez1]. This results in a compartment containing *C. burnetii* that displays the host autophagy proteins LC3 and Rab24 [@ppat.1004286-Romano1], and late endosomal/lysosomal proteins such as LAMP1, cathepsin D and the vacuolar type H+ ATPase [@ppat.1004286-Heinzen1]. It has been shown recently that the CCV accumulates host cholesterol resulting in robust localization of lipid raft proteins flotilin 1 and 2 and that this vacuole is encompassed by an F-actin cage [@ppat.1004286-Howe2], [@ppat.1004286-Aguilera1]. Thus, the CCV is a unique pathogen-occupied organelle that is generated upon fusion with host lysosomes.

Another unique feature of the CCV is that it has the ability to fuse promiscuously with other endosomal compartments in the cell, which consumes cellular lysosomes and results in the formation of a large lysosome-derived compartment in the infected cell [@ppat.1004286-Howe3], [@ppat.1004286-Howe4]. Co-infection studies have shown that the ability of the CCV to fuse with other endocytic compartments will promote fusion of pre-existing phagolysosomes containing inert latex-bead particles with the CCV and will also promote the fusion of vacuoles containing other pathogenic microbes with the CCV [@ppat.1004286-Veras1], [@ppat.1004286-Gomes1]. Importantly, if a cell is independently infected with multiple *C. burnetii*, the ability of the bacteria to stimulate homotypic fusion of lysosome-derived compartments will lead to the formation of a single CCV in the infected cell [@ppat.1004286-Howe4]. Inhibition of bacterial protein synthesis after infection prevents bacterial manipulation of endosomal dynamics and results in contraction of the spacious CCV to create a tight-fitting membrane that surrounds bacteria residing in the CCV lumen [@ppat.1004286-Howe4]. In addition to manipulating the host membrane transport and fusion pathways to produce a mature CCV, *C. burnetii* also promotes host viability by actively preventing apoptosis [@ppat.1004286-Luhrmann1], [@ppat.1004286-Voth1]. Manipulation of membrane transport and inhibition of apoptosis are both predicted to be pathogen-directed strategies that enable *C. burnetii* to replicate efficiently in mammalian host cells.

Deciphering the unique molecular mechanisms that *C. burnetii* uses to manipulate the host has become possible with the development of axenic culture conditions. Formerly classified as an obligate intracellular bacterium, it has been shown that *C. burnetii* replicates axenically in Acidified Cysteine Citrate Media (ACCM) with 5% CO~2~ and low oxygen conditions [@ppat.1004286-Omsland1], [@ppat.1004286-Omsland2]. Subsequently, genetic approaches were developed to isolate transposon-insertion mutants and mutants with targeted gene deletions [@ppat.1004286-Beare1]--[@ppat.1004286-Beare3], which were used to demonstrate that the Dot/Icm type IVB secretion system encoded by *C. burnetii* is essential for intracellular replication [@ppat.1004286-Beare3]--[@ppat.1004286-Beare4]. This secretion system is genetically and functionally related to the Dot/Icm system of the human pathogen *Legionella pneumophila* [@ppat.1004286-Seshadri1]--[@ppat.1004286-Zusman1]. In *L. pneumophila*, the Dot/Icm system facilitates intracellular replication by translocating into the host cytosol approximately 300 different effector proteins [@ppat.1004286-Hubber1]. These effectors rapidly modulate the host cell biology to direct the remodeling of the *Legionella*-containing vacuole (LCV), which prevents fusion with lysosomes and promotes fusion of secretory vesicles to create a vacuole that supports intracellular replication [@ppat.1004286-Hubber1]. The biochemical function of a small proportion of these effectors has been elucidated but correlating these functions to pathogenesis is hampered by a large degree of functional redundancy both in terms of multiple paralogs with mirroring functions [@ppat.1004286-Luo1] and dissimilar effectors targeting the same host cell pathways [@ppat.1004286-Dorer1], [@ppat.1004286-OConnor1]. With few exceptions, deletion of a gene encoding a *L. pneumophila* effector does not typically have a measurable impact on the ability of the bacterium to replicate intracellularly. It is thought that the diversity of the natural protozoan hosts *L. pneumophila* encounters in nature has resulted in the selection of functionally-redundant effectors that mediate survival in specific protozoan hosts [@ppat.1004286-OConnor1].

The *L. pneumophila* Dot/Icm system initiates effector translocation immediately upon contact with a host to prevent the LCV from engaging the host endocytic pathway [@ppat.1004286-Roy1], [@ppat.1004286-Nagai1]. By contrast, the *C. burnetii* Dot/Icm system does not translocate effectors until the bacteria are delivered to lysosomes and become metabolically active in an acidified vacuole [@ppat.1004286-Newton1]. Given their divergent intracellular infection strategies it is predicted that there will be minimal overlap in the function of the effectors encoded by *L. pneumophila* when compared to *C. burnetii*, which is supported by the observation that few *bone fide* homologs of *L. pneumophila* effectors are encoded in the *C. burnetii* genome. To date, over 100 *C. burnetii* Dot/Icm effectors have been identified using a range of methods [@ppat.1004286-Carey1], [@ppat.1004286-Pan1]--[@ppat.1004286-Weber1]. The translocation of the majority of these effectors was observed using *L. pneumophila* as a surrogate effector delivery platform. Several *C. burnetii* effectors have been implicated in preventing apoptosis [@ppat.1004286-Luhrmann2], [@ppat.1004286-Klingenbeck1], including the ankyrin repeat-containing protein AnkG that infers an anti-apoptotic phenotype on *L. pneumophila* [@ppat.1004286-Luhrmann2]. It is predicted that *C. burnetii* effectors will also function to control membrane traffic, as demonstrated by the effector CvpA interacting with clathrin-coated vesicles [@ppat.1004286-Larson1], and to manipulate other aspects of the host biology important for intracellular replication. Because *C. burnetii* replicates exclusively inside mammalian hosts it is predicted that there will be less functional redundancy in the cohort of *C. burnetii* effector proteins compared to what is observed for *L. pneumophila* effector proteins, and that loss of single effectors may impact CCV formation. This means that it should be possible to identify effectors important for intracellular replication, and that determining the function of these effectors will increase our understanding of CCV development.

Here, we conducted a visual screen on an arrayed library of random transposon insertion mutants of *C. burnetii* NMII to identify genes important for formation of the mature CCV. This approach was successful and resulted in the identification of genes that are important for the intracellular lifestyle of *C. burnetii*. The requirement for a functional Dot/Icm system in biogenesis of the CCV was evident. Insertions that inactivated genes encoding structural components of this secretion apparatus were identified in addition to insertions in genes encoding regulatory factors that govern expression of the Dot/Icm system. Importantly, these studies have identified several effector proteins that play important and distinct roles during intracellular replication. Specifically, using this approach we reveal a genetic interaction between the effector Cig2 and the host autophagy pathway. These data indicate that Cig2 function is required for robust interactions between the CCV and host autophagosomes, and that this maintains the CCV in an autolysosomal stage of maturation.

Results {#s2}
=======

Construction of an arrayed library of *C. burnetii* transposon mutants {#s2a}
----------------------------------------------------------------------

The plasmid pKM225 encoding a Himar1 TnA7 transposase was used to introduce a transposon encoding chloramphenicol resistance and a mCHERRY fluorescent protein randomly onto the genome of the *C. burnetii* NMII strain RSA493. The mutagenesis procedure was optimized to reduce isolation of siblings containing identical transposon insertions and to reduce the number of spontaneous mutants defective for Dot/Icm function (described in [Materials and Methods](#s4){ref-type="sec"}). After optimization, 3,840 transposon insertion mutants were isolated as single clones from 40-independent pools. These clones were then arrayed and expanded in 96-well plates containing ACCM-2. We were successful in expanding 84.6% of the clones (3,237 mutants) in liquid ACCM-2 under antibiotic selection. To determine the degree to which these clones represented independent mutants with different sites of transposon insertion, we determined the site of insertion for a total of 459 mutants using a two-stage semi-degenerate PCR amplification and sequencing protocol. This analysis confirmed that isolated clones had single transposon insertions distributed randomly across the *C. burnetii* genome. Additionally, this analysis revealed several mutants that had transposon insertions in genes encoding known effectors of the Dot/Icm system ([Tables S1](#ppat.1004286.s003){ref-type="supplementary-material"}, [S2](#ppat.1004286.s004){ref-type="supplementary-material"}, [S3](#ppat.1004286.s005){ref-type="supplementary-material"}, [S4](#ppat.1004286.s006){ref-type="supplementary-material"}, [S5](#ppat.1004286.s007){ref-type="supplementary-material"}).

A visual screen identifies *C. burnetii* mutants with vacuole biogenesis defects {#s2b}
--------------------------------------------------------------------------------

The arrayed library of *C. burnetii* NMII transposon mutants was analyzed using a visual assay that assessed the ability of individual mutants to form vacuoles that support intracellular replication. Specifically, HeLa 224 cells distributed in 96-well glass-bottom plates were infected with individual mutants at an MOI of approximately 500 and then the cells were incubated for 96 h. Cells were fixed and stained with antibodies specific for *Coxiella* (red) and LAMP1 (green), and the DNA was labeled with Hoechst dye (blue). The ability of each mutant to form a vacuole that supported intracellular replication was assessed by direct examination using fluorescence microscopy. Importantly, the parental NMII control strain and most of the *C. burnetii* transposon insertion mutants formed a single spacious vacuole filled with replicating bacteria ([Figure 1A](#ppat-1004286-g001){ref-type="fig"}). Additionally, of the 459 mutants for which the transposon insertion site was determined, we found that 324 mutants (71%) did not display a discernable vacuole formation defect in this visual assay, which included several mutants having insertions in genes encoding known effectors of the Dot/Icm system ([Table S5](#ppat.1004286.s007){ref-type="supplementary-material"}). Lastly, as described in detail below, many of the mutants that displayed vacuole formation defects had insertions in genes that would be predicted to affect intracellular replication. Thus, confidence was high that this screen would identify a unique cohort of genes important for *C. burnetii* replication in mammalian cells.

![Transposon mutants of *C. burnetii* display different intracellular phenotypes.\
Transposon mutants were subject to a vacuole formation assay in which 96-well plates of HeLa 229 cells were infected, at an MOI of approximately 500, with individual transposon mutants. Following a 96 h infection period, the infection was fixed and stained with anti-*Coxiella* (red), anti-LAMP1 (green) and Hoechst dye (blue) and observed with low magnification fluorescence microscopy. (A) The parental strain *C. burnetii* NMII displayed a large CCV in the majority of HeLa cells. (B) A cohort of mutants showed no intracellular replication as demonstrated by *dotA*::Tn, (C) another category produced smaller replicative vacuoles such as that seen with *cig57*::Tn, (D) transposon insertions that disrupted *cig2* resulted in the appearance of multiple vacuoles in a single cell, and (E) a small proportion of mutants, such as *gidA*::Tn, displayed CCVs with an abnormal shape due to filamentous replication of the *C. burnetii*.](ppat.1004286.g001){#ppat-1004286-g001}

There were four distinct mutant phenotypes revealed in this visual screen ([Figure 1](#ppat-1004286-g001){ref-type="fig"}). A severe defect characterized as no detectible intracellular replication in the visual screen was observed for 74 mutants having transposon insertions that were distributed among 21 different protein-coding regions and six different intergenic regions ([Table S1](#ppat.1004286.s003){ref-type="supplementary-material"}). At 96 h post-infection these mutants were observed as single bacteria inside of LAMP1-positive vacuoles ([Figure 1B](#ppat-1004286-g001){ref-type="fig"}). Forty-two transposon mutants displayed a reduced ability to replicate intracellularly as determined by their presence in small vacuoles containing fewer bacteria compared to vacuoles containing the control strain ([Figure 1C](#ppat-1004286-g001){ref-type="fig"}, [Table S2](#ppat.1004286.s004){ref-type="supplementary-material"}). Nine transposon mutants displayed filamentous growth inside of host cells ([Figure 1E](#ppat-1004286-g001){ref-type="fig"}, [Table S3](#ppat.1004286.s005){ref-type="supplementary-material"}), suggesting that these bacteria were under stress or defective for cell division. Lastly, there were 10 transposon mutants isolated independently that displayed a multi-vacuolar phenotype, which was characterized by the appearance of infected host cells that contained multiple vacuoles each supporting replication of *C. burnetii* ([Figure 1D](#ppat-1004286-g001){ref-type="fig"}, [Table S4](#ppat.1004286.s006){ref-type="supplementary-material"}). Importantly, every mutant we identified that displayed this multi-vacuolar phenotype had a transposon insertion in the 2,430 bp region encoding the protein Cig2 (Cbu0021).

Genes essential for Dot/Icm function are highly represented among the mutants defective for intracellular replication {#s2c}
---------------------------------------------------------------------------------------------------------------------

Mutants with transposon insertions in the genes *icmL.2* or *icmD* and mutants with targeted deletions of the genes *dotA* or *dotB* were shown previously to be defective for intracellular replication [@ppat.1004286-Beare3]--[@ppat.1004286-Beare4], which established the essential role the Dot/Icm system has in *C. burnetii* pathogenesis. Here, we identified 66 different intracellular growth mutants harboring a transposon insertion in *dot* and *icm* loci and three mutants that were severely attenuated for intracellular replication with insertions in this region ([Figure 2A](#ppat-1004286-g002){ref-type="fig"}). The observation that many of the intracellular growth mutants have insertions in the region encoding the Dot/Icm system, as well as the extensive coverage of this region that was obtained, provides addition evidence that the arrayed mutant library contains a random distribution of transposon insertions. Additionally, this analysis indicates that spontaneous unlinked mutations that affect Dot/Icm function did not occur at a high frequency. This was a concern because if spontaneous *dot* and *icm* mutants were encountered at a high frequency then the mutant library would not be effective at identifying effectors essential for intracellular replication, and most intracellular growth phenotypes would not be complemented *in trans* upon introducing plasmids encoding the wild type allele of the disrupted gene. In the pool of 450 transposon mutants that were sequenced, we identified multiple insertion mutations in the coding region located between the *icmQ* and *icmT* genes ([Figure 2A](#ppat-1004286-g002){ref-type="fig"}). No defects in CCV biogenesis were observed for these mutants, indicating that the genes in this region are not essential for Dot/Icm function. Also, we determined that the hypothetical protein Cbu1651 encoded in this region was not essential for Dot/Icm function because the mutant 16-E10 had an insertion in the *cbu1651* coding region but did not have a vacuole biogenesis defect. Two mutants with the transposon inserted at the 3′ end of the *cbu1651* gene displayed a vacuole biogenesis defect, however, these insertions are predicted to negatively affect expression of *icmX*, which is a gene essential for Dot/Icm function [@ppat.1004286-Matthews1].

![The Dot/Icm system and the PmrAB system are essential for intracellular replication and delivery of *C. burnetii* effector proteins.\
(A) Indicated are the locations of transposon insertions in the chromosomal regions encoding the Dot/Icm system from 1559100 bp to 1591800 bp, and (B) the PmrAB two-component regulatory system from 1176500 to 1179500 bp. The site of each transposon insertion is represented by an arrow. The mutants that could not replicate intracellularly were assigned red arrows, mutants that produced normal CCVs were assigned black arrows, and mutants that formed small vacuoles were assigned grey arrows. (C) The plasmids pBlaM and pBlaM-77 were introduced into *C burnetii* NMII (black bars) and *pmrA*::Tn (grey bars) to determine whether the PmrAB system was essential for effector translocation. Cleavage of the fluorescent β-lactamase substrate CC4F-AM was determined by calculating the ratio of fluorescence at 460 nm to 535 nm relative to uninfected cells. The graph shows the mean ± SD calculated for three independent samples.](ppat.1004286.g002){#ppat-1004286-g002}

Previously, it was demonstrated that the *C. burnetii icmD* gene was required for intracellular replication [@ppat.1004286-Beare4]. Additionally, studies on *L. pneumophila* predict that *icmC, icmN, icmT* and *dotD* should also be important for function of the *C. burnetii* Dot/Icm system [@ppat.1004286-Yerushalmi1]--[@ppat.1004286-Segal2], and a recent independent study has shown that *C. burnetii* mutants deficient in *dotD*, *icmC* and *icmN* display intracellular replication defects [@ppat.1004286-Martinez1]. Although complementation studies and in-frame deletion analysis was not used to more precisely determine the specific *dot* and *icm* genes that were essential for intracellular replication, the region itself was highly represented among mutants with severe intracellular growth defects, which suggested that it should be possible to identify other important genes required for intracellular replication using this library of transposon mutants.

The two-component regulatory system PmrAB is required for Dot/Icm effector translocation {#s2d}
----------------------------------------------------------------------------------------

The response regulator PmrA of *L. pneumophila* is important for intracellular growth of this pathogen as it controls the expression of genes encoding components of the Dot/Icm system and many effectors [@ppat.1004286-Zusman2]. The *C. burnetii cbu1227* gene encodes a PmrA homologue [@ppat.1004286-Zusman2], which was initially annotated as QseB [@ppat.1004286-Seshadri1]. The prediction is that PmrA activity is controlled by the sensor kinase PmrB encoded by an adjacent gene in the operon. At least 68 promoter regions in *C. burnetii* contain a consensus PmrA binding site, which included five promoter regions upstream of operons that encode most of the *dot* and *icm* genes [@ppat.1004286-Zusman2]. Thus, the prediction is that expression of most *C. burnetii dot* and *icm* genes will require a functional PmrAB system. Consistent with this hypothesis, among the *C. burnetii* mutants identified that were defective for vacuole biogenesis, we isolated three mutants with a transposon insertion in *pmrA*, one mutant with a transposon insertion in *pmrB*, and one mutant with a transposon insertion in the regulatory region upstream of *pmrA* ([Figure 2B](#ppat-1004286-g002){ref-type="fig"}). To determine if the Dot/Icm system was operational in mutants defective for PmrAB function we introduced a plasmid encoding a β-lactamase reporter (BlaM) fused to the effector protein Cbu0077 that produces the hybrid protein BlaM-77. The BlaM-77 protein was produced in the *pmrA*::Tn mutant strain and effector protein translocation was assayed during host cell infection ([Figure 2C](#ppat-1004286-g002){ref-type="fig"}). This assay used the substrate CCF4-AM, which when loaded into cells fluoresces at 535 nm (green) following excitation at 415 nm. However, if BlaM-77 is translocated into the host cytosol during infection, the CCF4-AM molecule will be cleaved resulting in a shift in fluorescence to 460 nm (blue). No BlaM-77 translocation was detected when HeLa cells were assayed 24 h after infection with the *C. burnetii pmrA*::Tn mutant ([Figure 2C](#ppat-1004286-g002){ref-type="fig"}). Thus, the intracellular growth defect displayed by mutants defective in PmrAB function is likely due to a defect in Dot/Icm-dependent delivery of effector proteins important for vacuole biogenesis.

The effector protein Cig57 is important for intracellular replication {#s2e}
---------------------------------------------------------------------

Many *C. burnetii* NMII transposon mutants had an intracellular replication defect that resulted in a significant reduction in the size of vacuoles and the number of bacteria in each vacuole. Included in this category were three transposon insertions that were predicted to result in partial loss-of-function in the Dot/Icm system. These mutants included transposon insertions in the *icmS* gene encoding a chaperone protein that assists in effector translocation [@ppat.1004286-Cambronne1], a mutant with an insertion located in the 3′ region of *icmX* that would result in the production of an IcmX protein with a small C-terminal deletion, and a mutant with an insertion in the *cbu1651* gene that likely affects the expression of adjacent *dot* and *icm* genes.

Reduced intracellular replication was also observed in mutants having insertions in genes encoding three different effector proteins, which were Cig57, CoxCC8 and Cbu1754. We isolated 10 intracellular growth mutants having a transposon insertion in *cig57* and the *cig57*::Tn mutant called 3-H3 was analyzed in detail. When intracellular replication was measured over a seven-day period, the 3-H3 strain displayed only a 5-fold increase in genome equivalents (GEs, [Figure 3](#ppat-1004286-g003){ref-type="fig"}). [Introduction](#s1){ref-type="sec"} of a plasmid-encoded triple FLAG-tagged version of 3×FL-Cig57 (pFLAG:Cig57) into the 3-H3 *cig57*::Tn mutant restored intracellular replication to levels that were equivalent to wild type *C. burnetii*, as determined by 237-fold increase in GEs after a 7-day infection period and the appearance by immunofluorescence microscopy of large spacious vacuoles containing replicating 3-H3 (pFLAG:Cig57) bacteria ([Figure 3B & 3C](#ppat-1004286-g003){ref-type="fig"}). Importantly, there were no obvious defects observed in the maturation of vacuoles containing 3-H3 as indicated by the presence of both LAMP1 ([Figure 3](#ppat-1004286-g003){ref-type="fig"}) and cathepsin D ([Figure S1](#ppat.1004286.s001){ref-type="supplementary-material"}) on the vacuoles formed by this mutant. Thus, the effector protein Cig57 likely has a role in modulating host processes important for replication that occur after *C. burnetii* is delivered to a lysosome-derived organelle.

![The Dot/Icm effector Cig57 is required for efficient intracellular replication of *C. burnetii*.\
(A) Intracellular replication of *C. burnetii* NMII (black squares), *cig57*::Tn (black triangles) and *cig57*::Tn pFLAG-Cig57 (open circles). The fold-increase in GEs relative to the inoculum was determined by *dotA*-specific qPCR and is represented here as the mean ± SD of 3 independent infections at days 1, 3, 5 and 7 post-infection. (B,C) Representative micrographs of HeLa cells infected for either 3 days (B) or 5 days (C) with *C. burnetii* NMII, *cig57*::Tn or *cig57*::Tn pFLAG-Cig57. Cell with stained with anti-*Coxiella* antibody (red), anti-LAMP1 antibody (green) and Hoechst dye (blue). Note that the vacuoles containing *cig57*::Tn were smaller and contained few bacteria at each time point compared to the control NMII strain or the complemented *cig57*::Tn pFLAG-Cig57 strain. Scale bars represent 10 µm.](ppat.1004286.g003){#ppat-1004286-g003}

Screening for intracellular growth mutants identifies a new Dot/Icm effector protein {#s2f}
------------------------------------------------------------------------------------

We identified a strain of *C. burnetii* having a transposon insertion in the gene *cbu1780* and a strain having an insertion in the gene *cbu2072* that had both displayed a severe intracellular growth defect. Both of these genes encode hypothetical proteins, which raised the possibility they might encode novel effectors. To determine if these proteins might encode effectors both Cbu1780 and Cbu2072 were tested for Dot/Icm-dependent translocation using fusion proteins having an amino-terminal BlaM reporter. The resulting BlaM-1780 and BlaM-2072 fusion proteins were produced in *C. burnetii* NM II and the isogenic *icmL*::Tn strain. The BlaM-1780 fusion protein was translocated into the host cytosol when produced in *C. burnetii* with a functional Dot/Icm system, as determined by a significant increase in the 460::535 nm fluorescence ratio to 24.62±2.70. By contrast, no translocation was detected by BlaM-2072, 1.07±0.86. Similarly no translocation was detected for the controls, which included BlaM-1780 and BlaM-2072 produced in the Dot/Icm-deficient mutant and BlaM alone produced in the parental *C. burnetii* NMII strain ([Figure S2](#ppat.1004286.s002){ref-type="supplementary-material"}). Thus, Cbu1780 is an effector protein that has an important role during infection.

The effector Cig2 is required for homotypic fusion of CCVs {#s2g}
----------------------------------------------------------

A striking phenotype that resulted in the appearance of multiple CCVs in HeLa cells that were infected by *C. burnetii* was observed for 10 independent transposon insertion mutants ([Figure 1D](#ppat-1004286-g001){ref-type="fig"}). Because individual vacuoles containing replication-competent *C. burnetii* will undergo homotypic fusion inside of an infected cell this phenotype suggests that these mutants were defective in promoting homotypic fusion of the CCV. All of the mutants identified that displayed this multi-vacuolar phenotype had a transposon insertion in the gene encoding the hypothetical protein Cig2 (Cbu0021), which was recently postulated to be an effector because it could be translocated by the *L. pneumophila* Dot/Icm system [@ppat.1004286-Lifshitz1]. The mutants 3-C3 and 1-D12 producing normal CCVs had a transposon insertion in the neighboring gene *cbu0022* and in between *cbu0022* and *cbu0023*, respectively. Thus, it was unlikely that the multi-vacuole phenotype displayed by the *cig2*::Tn insertion mutants was due to a polar effect on expression of downstream genes. When a plasmid encoding the 3×FL-Cig2 protein (pFLAG:Cig2) was introduced into the *cig2*::Tn mutant strain 2-E1 the resulting 2-E1 (pFLAG:Cig2) strain displayed mainly single vacuoles at 72 h post-infection, which was similar to host cells infected with the wild type *C. burnetii* NMII strain under these same conditions ([Figure 4](#ppat-1004286-g004){ref-type="fig"}). Despite the multi-vacuole phenotype, the *cig2*::Tn mutants formed vacuoles that permit bacterial replication ([Figure 4A](#ppat-1004286-g004){ref-type="fig"}). Growth curves confirmed that the *cig2*::Tn mutants were not defective for replication in HeLa cells ([Figure 4C](#ppat-1004286-g004){ref-type="fig"}), which suggests that *cig2* might encode an effector that is required uniquely for processes important for homotypic vacuole fusion. Production of a BlaM-Cig2 protein in *C. burnetii* NMII revealed that Cig2 was translocated during host cell infection and that translocation of BlaM-Cig2 by *C. burnetii* required the Dot/Icm system ([Figure 4D](#ppat-1004286-g004){ref-type="fig"}). Thus, these data indicate that the Cig2 protein is a translocated effector required for homotypic fusion of the CCV.

![The Dot/Icm effector Cig2 is necessary for homotypic fusion of CCVs.\
(A) HeLa cells were infected with *C. burnetii* NMII strains at an MOI of 500. Five days post-infection the infections were fixed and stained with anti-*Coxiella* (red), anti-LAMP1 (green) and Hoechst dye (blue). Representative micrographs demonstrate the multiple vacuole phenotype observed for the *cig2*::Tn mutant strain. \* indicates the location of individual CCVs within a chosen cell. These CCVs were identified both by LAMP1 staining and phase contrast microscopy. Scale bars represent 10 µm. (B) The average number of vacuoles containing *C. burnetii* NMII (black bars), *cig2*::Tn (white bars) and *cig2*::Tn pFLAG:Cig2 (grey bars) was determined at day 3 post-infection for at least 100 infected cells on duplicate coverslips. Data are the mean ± SD from 3 independent experiments. (C) Replication of *cig2*::Tn (open triangles) and the parental *C. burnetii* NMII strain (black squares) was determined by measuring genome equivalents over a 7 day infection period. (D) Micrographs from translocation assays using *C. burnetii* NMII and the *icmL*::Tn strains producing either BlaM alone (pJB-Cm:BlaM) or BlaM-Cig2 (pJB-Cm:BlaM-Cig2). Fluorescence intensity at 535 nm of uncleaved CCF4-AM is shown in green. Fluorescence intensity of cleaved CCF4-AM at 460 nm generated by the enzymatic activity of BlaM fusion proteins delivered into the host cell cytosol is shown in blue. These images are representative of 3 independent experiments.](ppat.1004286.g004){#ppat-1004286-g004}

Host autophagy is required for Cig2-dependent homotypic fusion of CCVs {#s2h}
----------------------------------------------------------------------

Previous studies have revealed a multi-vacuolar phenotype when the host gene encoding Syntaxin-17 (STX17) was silenced in HeLa cells and the STX17-silenced cells were then infected with NMII [@ppat.1004286-McDonough1]. The similarity between the phenotype in STX17-silenced cells and the multi-vacuole phenotype observed for the *cig2*::Tn mutant suggested a genetic interaction between Cig2 and STX17. Recent data has shown that STX17 has an essential role in the host process autophagy [@ppat.1004286-Hamasaki1], [@ppat.1004286-Itakura1], which would suggest autophagy might be required for homotypic fusion of CCVs. LC3 is a protein that is attached to autophagosomal membranes [@ppat.1004286-Kabeya1], and is important for autophagosome biogenesis and the selection of intracellular cargo that will be enveloped by autophagy. Consistent with the hypothesis that autophagy may be subverted during *C. burnetii* infection, it has been shown that LC3 is present on the CCV [@ppat.1004286-Romano1]. To determine if autophagy is required for CCV homotypic fusion, we used siRNA to silence the genes encoding the essential autophagy factors ATG5 and ATG12, and vacuole biogenesis was assayed by immunofluorescence microscopy. Compared to mock-transfected cells or cells where the control protein syntaxin-18 (STX18) was silenced, there was a significant increase in the percentage of *C. burnetii*-infected cells having two or more vacuoles per cell when the genes encoding the autophagy factors ATG5, ATG12, or STX17 were silenced ([Fig. 5A & B](#ppat-1004286-g005){ref-type="fig"}). Thus, a functional host autophagy system is required for Cig2-dependent homotypic fusion of the CCV.

![Autophagy is required for homotypic fusion of CCVs.\
(A) HeLa cells in which the indicated genes were silenced using siRNA were infected with *C. burnetii* and fixed 3 days post-infection before immunostaining with anti-*C. burnetii* (red) and anti-LAMP1 (green) antibodies. DNA was stained with Hoechst (blue). Shown are representative micrographs for mock-transfected cells and cells transfected with siRNA specific to human ATG5, ATG12, STX17, and STX18. (B) Single-cell quantification of *C. burnetii* vacuole counts in ATG5, ATG12, and STX17 siRNA-transfected HeLa cells compared to STX18-transfected cells and mock-transfected cells at 3 days post-infection. The percentages of infected cells with two or more *C. burnetii* vacuoles were counted. Shown is the mean ± SD from 3 independent experiments. (C) HeLa cells infected with *C. burnetii* expressing the *L. pneumophila* effector RavZ from a plasmid (3×FL-RavZ) were assayed 3 days after infection and scored for the multi-vacuolar phenotype. As controls, *C. burnetii* expressing empty vector (3×FL) or a point mutant of RavZ defective in autophagy inhibition (3×FL-RavZ~C258A~) were used. Shown are representative fluorescent images for each *C. burnetii* infection. (D) Immunoblots from uninfected or *C. burnetii*-infected HeLa cell lysates showing bands for non-lipidated (LC3-I) and lipidated (LC3-II) forms of LC3 and actin. Cells were untreated (top images) or treated (bottom images) with bafilomycin A1 and rapamycin for 2 h prior to lysis. Cells were infected with a Dot/Icm-deficient strain of *C. burnetii* (*icmL*::Tn), infected with parental *C. burnetii* NMII (no vector), or *C. burnetii* NMII with vector alone or vectors producing the indicated RavZ proteins. (E) Single-cell quantification of *C. burnetii* vacuole counts in cells at 3 days post-infection. The percentages of infected cells with two or more *C. burnetii* vacuoles were counted. Shown is the mean ± SD from three independent experiments.](ppat.1004286.g005){#ppat-1004286-g005}

The *L. pneumophila* Dot/Icm effector RavZ is translocated into the host cell during infection and inhibits autophagy by directly uncoupling ATG8 proteins attached to autophagosomal membranes, which includes LC3 [@ppat.1004286-Choy1]. We generated a *C. burnetii* strain that produces 3×FL-RavZ to determine if autophagy is important during the initial stage of infection when the Dot/Icm system is silent or during a later stage of infection when effectors are delivered into host cells. HeLa cells infected with *C. burnetii* producing 3×FL-RavZ had an autophagy defect as determined by the reduction in lipidated LC3-II protein when compared to uninfected cells or cells infected with *C. burnetii* producing the catalytically-inactive 3×FL-RavZ~C258A~ protein ([Fig. 5D](#ppat-1004286-g005){ref-type="fig"}). Importantly, most of the cells infected with *C. burnetii* producing functional 3×FL-RavZ displayed the multi-vacuolar phenotype defined by the presence of two or more vacuoles containing *C. burnetii*, whereas cells producing the catalytically inactive 3×FL-RavZ~C258A~ protein did not ([Fig. 5C & E](#ppat-1004286-g005){ref-type="fig"}). Thus, Dot/Icm-mediated delivery of 3×FL-RavZ interfered with homotypic fusion of the CCV by blocking autophagy after bacteria had been transported to a lysosome-derived compartment in the cell, which indicates that Cig2-mediated homotypic fusion of the CCV requires membranes that display lipidated ATG8 proteins.

The effector Cig2 is important for CCV fusion with autophagosomes {#s2i}
-----------------------------------------------------------------

The finding that defects in host autophagy or loss-of-function mutations in *cig2* both result in a multi-vacuolar phenotype suggested that *C. burnetii* might subvert host autophagy by a Cig2-dependent mechanism. Consistent with this hypothesis we found that the host autophagy protein LC3 was abundant on large vacuoles containing the parental NMII strain, whereas vacuoles containing the isogenic *cig2*::Tn mutant had a severe defect in LC3 accumulation ([Figure 6A & B](#ppat-1004286-g006){ref-type="fig"}). LC3 accumulation at the CCV was restored when a plasmid encoding 3×FL-Cig2 was introduced into the *cig2*::Tn mutant. To determine if Cig2 may increase autophagy flux in infected cells the autophagy rates were assessed after infection by measuring the accumulation of lipidated LC3-II in cells. There was no appreciable difference in the amounts of lipidated LC3-II detected by immunoblot analysis when cells infected with the *cig2*::Tn mutant strain were compared with cells infected with the parental NMII strain of *C. burnetii* or compared to uninfected cells ([Figure 6C](#ppat-1004286-g006){ref-type="fig"}). Similar results were observed when autophagy flux was activated through rapamycin treatment of cells and LC3-II levels were stabilized by interfering with lysosome degradation using bafilomycin A1 ([Figure 6C](#ppat-1004286-g006){ref-type="fig"}). By contrast, a drop in LC3-II levels was measured in cells infected with *C. burnetii* producing 3×FL-RavZ, which results from ability of this effector to deconjugate LC3-II from membranes ([Figure 6C](#ppat-1004286-g006){ref-type="fig"}). These data indicate that infection by *C. burnetii* does not elevate the basal rate of autophagy and that Cig2 function does not affect autophagy flux during infection.

![The effector Cig2 is important for CCV fusion with autophagosomes.\
(A) HeLa cells were infected with *C. burnetii* NMII, *cig2*::Tn or *cig2*::Tn pFLAG:Cig2 for 5 days and stained with anti-LC3 (green) and anti-*Coxiella* (red) antibodies. (B) The association of LC3 with the CCV was quantified by observing 100 infected cells per sample in 3 independent experiments. (C) LC3 and actin immunoblots from HeLa cells infected with parental *C. burnetii* NMII, the *cig2*::Tn mutant, the parental *C. burnetii* NMII producing either RavZ or RavZ~C258A~, or uninfected cells. Cells were untreated (top image), or treated (bottom image) with bafilomycin A1 and rapamycin for 2 h prior to lysis. (D) J774A.1 cells were infected with *C. burnetii* NMII, *cig2*::Tn, or *cig2*::Tn pFLAG:Cig2 for 36 h before loading with 50 µg/ml DQ Green BSA for 16 h. Micrographs show phase contrast images to reveal vacuoles and the green fluorescence that results from DQ Green BSA degradation by proteases in lysosomal compartments.](ppat.1004286.g006){#ppat-1004286-g006}

Lastly, we asked whether the CCV created by the *cig2*::Tn mutant was still accessible to fluid-phase endocytic transport and whether the lumen of the vacuole remained hydrolytic. This question was addressed by pulsing infected macrophages with soluble DQ Green BSA added to the extracellular medium. Endocytic transport and cleavage of DQ Green BSA by lysosomal proteases generates fluorescent peptides that permit visualization of hydrolytic organelles by fluorescence microscopy. Similar to the organelles formed by the parental NMII strain and the *cig2*::Tn mutant complemented with the plasmid producing 3×FLAG-Cig2, the vacuoles containing the Cig2-deficient mutants retained the ability to cleave DQ Green BSA as indicated by the green fluorescence localized to the CCV ([Figure 6D](#ppat-1004286-g006){ref-type="fig"}), which is consistent with the finding that these vacuoles contain the lysosomal protease Cathepsin D ([Figure S1](#ppat.1004286.s001){ref-type="supplementary-material"}). These data indicate that compared to vacuoles formed by the parental NMII strain, the lumen of the vacuole containing the *cig2*::Tn mutant has a similar capacity to receive endocytic cargo and hydrolyze proteins. Thus, Cig2 function is required to promote fusion of autophagosomes with the initial acidified lysosome-derived vacuole in which *C. burnetii* resides.

Discussion {#s3}
==========

Here we employed large-scale transposon mutagenesis to create an arrayed library of 3,237 *C. burnetii* transposon insertion mutants. The *C. burnetii* NMII RSA 493 genome is comprised of a chromosome that is 1,995,275 bp and a 37,393 bp plasmid called QpH1 [@ppat.1004286-Seshadri1]. The total number of mutants obtained would correlate with at least one insertion for every 628 bp of DNA assuming the transposon we used inserted randomly in the genome. Given that the average size of a *C. burnetii* open reading frame is 849 bp most non-essential genes should be present in the library. Consistent with these calculations, our screen identified insertions in most of the *dot* and *icm* genes predicted to be non-essential for axenic growth of *C. burnetii*. There were, however, also 10 independent insertions isolated in the 2,430 bp gene *cig2*, which is higher than would be predicted given random distribution of the transposon throughout the genome. Thus, we are confident that insertions in most of the genes required for intracellular infection by *C. burnetii* but not for replication in axenic medium were represented in this arrayed library of mutants; however, we acknowledge that there are difficulties in reaching saturation of the genome by transposon mutagenesis that could result in a several genes required for intracellular replication not being present in this library.

We found that loss-of-function mutations in the PmrAB two-component regulatory system abolished intracellular replication of *C. burnetii*, which is consistent with independent data reported in two recent studies [@ppat.1004286-Martinez1], [@ppat.1004286-Beare5]. Thus, regulation of the Dot/Icm system and associated effectors by the PmrAB proteins is essential for intracellular replication. Reduced intracellular replication was also observed for *C. burnetii* with insertions in the putative regulatory genes *cbu1761* and *vacB*. The gene *cbu1761* encodes a putative sensor histidine kinase with no apparent cognate response regulator and *vacB* is predicted to encode an exoribonuclease called RNase R. VacB homologs in *Shigella flexneri* and enteroinvasive *Escherichia coli* have been shown to play an important role in host virulence through post-transcriptional positive regulation of plasmid-encoded virulence genes [@ppat.1004286-Tobe1], [@ppat.1004286-Cheng1]. VacB is thought to mediate this regulatory control through its capacity to process mRNA. This suggests that in addition to PmrAB being required for transcription of genes in the Dot/Icm regulon that there are other virulence-associated circuits controlled by *C. burnetii* regulatory proteins.

Results from this screen provide initial evidence that redox metabolism is important during intracellular replication of *C. burnetii*. A mutant severely impaired for intracellular replication had an insertion in the gene *cbu2072* ([Table S1](#ppat.1004286.s003){ref-type="supplementary-material"} and [Figure S2](#ppat.1004286.s002){ref-type="supplementary-material"}). The inability to detect translocation of the BlaM-Cbu2072 fusion protein into the host cytosol during *C. burnetii* infection indicates Cbu2072 is unlikely to be an effector protein. Bioinformatic studies predict that the Cbu2072 protein has a molecular weight of 18.2 kDa and limited homology with soluble pyridine nucleotide transhydrogenases (30% identity over 50% of the protein). These enzymes provide an energy-independent means to maintain homeostasis between the two redox factors NAD(H) and NADP(H) [@ppat.1004286-Canonaco1]. Additional evidence that redox metabolism might be critical during intracellular replication is provided by the mutants 7-G9, 10-B8 and 23-H5 ([Table S2](#ppat.1004286.s004){ref-type="supplementary-material"}), which have independent transposon insertions in the *nadB* gene encoding L-aspartate oxidase. These *C. burnetii nadB* mutants had a moderate intracellular replication defect. NadB catalyzes a step in the quinolinate synthetase complex that generates quinolinic acid from aspartate [@ppat.1004286-Flachmann1]. Quinolinic acid acts as a precursor for the pyridine nucleotide of NAD. These processes may be specifically important for intracellular replication of *C. burnetii* given the high oxidative stress caused by residing in a lysosome-like organelle.

Several *C. burnetii* mutants were identified in the visual screen because they displayed a filamentous growth phenotype. Disruption of the two-component regulatory system encoded by *cbu2005* and *cbu2006*, *cbu0745*, *mnmA*, *ptsP* and *gidA* resulted in filamentous replication intracellularly. The protein Cbu0745 is predicted to be the *C. burnetii* homolog of ribosome-associated factor Y, and the proteins MnmA and GidA are enzymes involved in tRNA modification. Three independent mutants that displayed a filamentous growth phenotype were found to have insertions in the *gidA* gene, and previous studies indicate that disruption of *gidA* in *Salmonella* also results in bacteria that have defect in cell division resulting in filamentation [@ppat.1004286-Shippy1], [@ppat.1004286-vonMeyenburg1]. This *gidA* mutant phenotype has been attributed to an altered expression of genes responsible for cell division and chromosome segregation [@ppat.1004286-Shippy1]. Thus, it is likely that many of the *C. burnetii* mutants that demonstrate filamentation have defects in fundamental cellular processes including translation and chromosome segregation that affect cell division.

Specific Dot/Icm effector proteins critical for CCV biogenesis and intracellular replication of *C. burnetii* were identified in this visual screen. Three other recent studies have reported *C. burnetii* intracellular replication defects resulting from mutations in specific Dot/Icm effectors [@ppat.1004286-Weber1], [@ppat.1004286-Larson1], [@ppat.1004286-Martinez1]. By contrast, genetic screens to isolate intracellular replication mutants in *L. pneumophila* identified the Dot/Icm secretion system as being critical for intracellular replication, but did not reveal effector proteins that are essential for intracellular replication. To illustrate this point, it was shown that a *Legionella* strain having five large chromosomal deletions that eliminated the production of 71 different effector proteins could still replicate inside macrophages [@ppat.1004286-OConnor2], which provides further evidence that there is extensive functional redundancy built into the *Legionella* effector repertoire and this makes it difficult to identify effectors required for virulence by screening mutants for intracellular replication defects. Thus, the identification of effector mutants with strong intracellular growth phenotypes suggests that there is slightly less functional redundancy in the *C. burnetii* effector repertoire compared to *Legionella*. However, we identified mutants having transposon insertions in genes encoding 16 different effector proteins and were unable to detect any defects in intracellular replication or vacuole morphology for these effector mutants. Thus, it remains likely that there are functionally redundant effectors that modulate some of the host functions required for intracellular replication of *C. burnetii*. Additionally, it is likely that some of the effectors that are encoded by *C. burnetii* play important roles during infection of animals even though these effectors are not required for *C. burnetii* replication in host cells cultured *ex vivo*. Hypothetically, there could be effectors that modulate inflammation by preventing detection of *C. burnetii* by either innate or adaptive immune surveillance that would be predicted to fall into this category.

In our initial attempts at using transposon insertion mutagenesis to identify genes important for intracellular replication we were befuddled by loss-of-function mutations presumably arising spontaneously at a high frequency in *dot* and *icm* genes, which resulted in intracellular growth defects that were not linked to the site of transposon insertion. We optimized the mutagenesis protocol to reduce the probability of phenotypic differences being the result of spontaneous unlinked mutations. By either isolating multiple independent insertions in a gene where all mutants display the same phenotype or by complementing a phenotype by introducing a wild type allele on a plasmid, we demonstrate here that there are distinct phenotypes that are linked to transposon-mediated inactivation of a specific gene. However, it remains possible that some of the mutant phenotypes reported for insertion mutants described in the Supplemental Tables could be due to unlinked mutations and further studies are needed to support this initial analysis. Our data also suggest that unlinked mutations may have complicated results in a recent study where transposon insertions in genes encoding effector proteins were found to affect intracellular replication [@ppat.1004286-Weber1]. Complementation studies were not included in this study, which made it difficult to rule out the possibility that some of the transposon insertion mutants with intracellular growth defects had unlinked mutations that affect Dot/Icm function or the function of some other gene important for infection. For example, it was reported that a *cbu2052* transposon insertion mutant had an intracellular replication defect, however, we obtained two independent mutants with insertions in the *cbu2052* gene and immediately upstream of *cbu2052* ([Table S5](#ppat.1004286.s007){ref-type="supplementary-material"}) and both of these mutants formed CCVs that were indistinguishable from the vacuoles formed by the parental strain of *C. burnetii*. Thus, it is important that transposon insertion phenotypes in *C. burnetii* are validated using either complementation or allelic replacement approaches before important functions are assigned to effector proteins.

Ten intracellular replication mutants isolated in the screen were found to have independent insertions in the *cig57* gene and the intracellular replication defect displayed by a *cig57*::Tn mutant was complemented using a plasmid encoded *cig57* allele. Cig57 is highly conserved among sequenced *C. burnetii* strains, however, database searches did not identify other proteins with homology to Cig57. Thus, we can conclude with high confidence that Cig57 represents a unique effector protein that has an activity that is important for *C. burnetii* intracellular replication.

In addition to identifying mutants defective for intracellular replication, the visual screen revealed that *C. burnetii cig2* mutants display a multi-vacuole phenotype. Whereas infection of a single cell by multiple *C. burnetii* usually leads to formation of a single vacuole due to homotypic fusion of the individual CCVs, the vacuoles containing *cig2* mutants do not display the same propensity to fuse with each other inside the host cell, which results in a single host cell having multiple CCVs that each display LAMP1 and cathepsin D localization at the limiting membrane of the proteolytic lysosome-derived organelle. The *cig2* gene encodes a protein with a predicted molecular weight of 92.9 kDa. The Cig2 protein is encoded in the genomes of all sequenced strains of *C. burnetii*, however, the protein does not have homologs in other organisms and there are no conserved domains that might aid in predicting the biochemical functions of this protein. Our data demonstrate that Cig2 is translocated into host cells during infection by *C. burnetii* using a mechanism that requires the Dot/Icm system. Additionally, it has been shown that Cig2 produced in *Legionella* can be translocated into host cells by the Dot/Icm system [@ppat.1004286-Lifshitz1]. Thus, Cig2 represents a functional Dot/Icm effector protein that modulates vacuole biogenesis.

The multi-vacuolar phenotype displayed by *cig2*::Tn mutants was similar to the multi-vacuolar phenotype displayed after STX17 was silenced and HeLa cells were infected with the parental NMII strain [@ppat.1004286-McDonough1]. Why silencing of STX17 would result in a multi-vacuole phenotype was unclear initially, however, recent studies have shown that STX17 function is critical for autophagy in mammalian cells [@ppat.1004286-Hamasaki1], [@ppat.1004286-Itakura1]. This suggested that host autophagy was required for homotypic fusion of CCVs. Indeed, our data show that silencing host genes encoding essential component of the autophagy machinery resulted in the multi-vacuole phenotype in *C. burnetii*-infected cells. Additionally, when the LC3-deconjugating effector RavZ was introduced into *C. burnetii*, the RavZ-producing *C. burnetii* were able to disrupt host autophagy and this resulted in a multi-vacuole phenotype. These data provide a clear phenotypic link between the host autophagy system and Cig2 function.

Similar to the unregulated fusion that occurs between pre-existing phagolysosomes and the CCV in infected cells, upregulation of autophagy in mammalian cells generates large autolysosomal organelles as autophagosomes consume lysosomes through rapid fusion [@ppat.1004286-Yu1]. Importantly, independent studies have shown that LC3 associates with the CCV during vacuole biogenesis by an active process mediated by viable *C. burnetii* [@ppat.1004286-Romano1], [@ppat.1004286-Gutierrez1]. Additionally, it has been shown that the presence of LC3 on phagosome membranes will promote rapid fusion with lysosomes by a process known as LC3-associated phagocytosis [@ppat.1004286-Sanjuan1]. Thus, we hypothesized that the reason a *C. burnetii cig2* mutant displays a multi-vacuolar phenotype is because this effector is important for autophagy subversion by *C. burnetii*. Finding that there is defect in the localization of LC3 to vacuoles formed by Cig2-deficient *C. burnetii* supports this hypothesis. Finding that the rates of autophagy were similar following infection of cells with NMII or the isogenic *cig2*::Tn mutant indicates that Cig2 does not stimulate a general upregulation of autophagy flux in the infected cells. This suggests that Cig2 function is required to promote fusion of autophagosomes that are generated at a basal level in the infected cells with the CCV.

Based on these data, we propose a model whereby autophagy subversion by Cig2 is required to constitutively promote the fusion of autophagosomes with the CCV during infection. This would enable Atg8 proteins such as LC3 to be maintained on the CCV membrane and keep the CCV in autolysosomal stage of maturation. We postulate that by locking the CCV in an autolysosomal stage of maturation this vacuole would remain highly fusogenic, and this would promote homotypic fusion and fusion of the CCV with other lysosome-derived organelles in the cell. The result would be formation of a spacious CCV and the fusion of lysosome-derived organelles containing other bacteria or inert particles with the CCV. Determining whether this model is correct will require elucidating the biochemical function of Cig2 and a better understanding of the role autophagy subversion plays in generating the vacuole that *C. burnetii* occupies.

Materials and Methods {#s4}
=====================

Bacterial strains and host cell lines {#s4a}
-------------------------------------

Plaque purified *C. burnetii* Nine Mile phase II (NMII), strain RSA493 clone 4, was axenically grown in liquid ACCM-2 or ACCM-agarose at 37°C in 5% CO~2~ and 2.5% O~2~ as previously described [@ppat.1004286-Omsland2], [@ppat.1004286-Omsland3]. When appropriate, kanamycin and chloramphenicol were added to ACCM-2 at 300 µg/ml and 3 µg/ml respectively. HeLa 229 cells (CCL-2; ATCC, Manassas, VA) and J774.1 cells were maintained in Dulbecco\'s Modified Eagle\'s Media (DMEM) supplemented with 10% heat inactivated fetal bovine serum (FBS) at 37°C in 5% CO~2~.

Transposon mutagenesis of *C. burnetii* NMII {#s4b}
--------------------------------------------

pKM225 was introduced into stationary phase *C. burnetii* NMII via electroporation at 18 kV, 500 Ω and 25 µF as previously described [@ppat.1004286-Carey1], [@ppat.1004286-Omsland3]. Following electroporation, the bacteria were recovered in 20 ml of ACCM-2 for 24 h before being plated on ACCM-agarose plates containing chloramphenicol. After 6 days incubation, single colonies were isolated and resuspended in 1 ml aliquots of ACCM-2 with chloramphenicol in 24 well plates. Following a further 6 days, each 1 ml *C. burnetii* culture was passaged 1∶1000 to provide bacteria for the vacuole formation assay and determination of the transposon insertion site. The remaining culture was pelleted via centrifugation and resuspended in 100 µl of DMEM containing 10% FBS and 10% Dimethyl sulfoxide for storage in 96 well plates.

Determination of transposon insertion site {#s4c}
------------------------------------------

The genomic location of the transposon insert sites was determined for transposon mutants with distinct intracellular phenotypes and a wider random selection of recovered mutants. Nested primers within the transposon, facing the transposon-genome junction site, were used to amplify the insertion site either from *C. burnetii* cell lysate or purified genomic DNA. The first round of amplification used primer 1: GGGGGAAACGCCTGGTATC and a pool of random oligonucleotides with a common arm. The product of this PCR was used as a template for the second round of amplification with primer 2: GTCGGGTTTCGCCACCTC and primer ARB2: GGCCAGGCCTGCAGATGATG. The second PCR product was sequenced using primer 3: TCGATTTTTGTGATGCTCGTC. Sequencing results were analyzed using 4Peaks and BLAST programs.

Vacuole formation assay and immunofluorescence microscopy {#s4d}
---------------------------------------------------------

1.5×10^4^ HeLa 229 cells were added into 96 well tissue culture plates. The next day monolayers were infected with stationary phase *C. burnetii* transposon mutants at a multiplicity of infection (MOI) of approximately 500 in DMEM with 5% FBS. The infection was allowed to progress for approximately 96 h, with the media changed 24 h after infection. After 96 h, cells were fixed with 4% paraformaldehyde and then blocked and permeablized in blocking buffer (PBS containing 2% BSA and 0.05% saponin). The cells were stained with anti-LAMP1 monoclonal H4A3 (Developmental Studies Hybridoma Bank) and rabbit anti-*C. burnetii* polyclonal antibody in blocking buffer at 1∶1000 and 1∶10000 respectively. Secondary antibodies, Alexa Fluor 488 and 594 (Invitrogen) were used at 1∶3000 also in blocking buffer. During final PBS washes bacterial and host DNA was stained with Hoechst 33342 (Invitrogen). Stained infections were visually inspected for formation of large CCVs and those transposon mutants the exhibited abnormal CCV formation were investigated further. For additional immunofluorescence microscopy HeLa cells were added in 24-well dishes containing 10 mm glass coverslips. At the indicated times post-infection the cells were fixed and stained as above before being mounted on slides using ProLong Gold (Invitrogen). For cathepsin D staining of infected cells, anti-cathepsin D (Novus Biologicals) was used at 1∶50 following fixation and permeablized with ice-cold MeOH and blocking in PBS with 2% BSA. For endogenous LC3 staining HeLa cells were infected for five days before fixing in cold methanol on ice for five minutes. Coverslips were blocked in 2%BSA, and stained with mouse anti-LC3 (NanoTools clone 2G6) and rabbit anti-*Coxiella* antibodies at 1∶200 and 1∶10,000, respectively, in blocking solution. Cells were washed three times in PBS and stained with anti-mouse 488 and anti-rabbit 546 at 1∶2000. Coverslips were washed three times with PBS and mounted on slides using ProLong Gold Antifade reagent (Invitrogen). Images for endogenous LC3 were acquired using an LSM510 confocal microscope equipped with a 100×/1.4 numerical aperture objective lens. Images were analyzed in Image J and Photoshop. For DQ Green BSA experiments, J774A.1 cells were infected with *C. burnetii* NMII, *cig2*::Tn, or *cig2*::Tn pFLAG-Cig2 in 35 mm glass bottom dishes. Cells were incubated in medium containing 50 µg/ml DQ Green BSA at 36 h post-infection and allowed to incubate for a further 16 h. Cells were washed three times with PBS and placed in fresh 5% FBS/DMEM (no phenol red) as described previously [@ppat.1004286-Howe1]. Live images were acquired after one additional hour of incubation with the fresh media. Digital images were acquired with a Nikon Eclipse TE2000-S inverted fluorescence microscope using a 60×/1.4 or 100×/1.4 numerical aperture objective lens and a Photometrics CoolSNAP EZ camera controlled by SlideBook v.5.5 imaging software.

*C. burnetii* intracellular growth curves {#s4e}
-----------------------------------------

The day before infection, HeLa 229 were plated at a density of 5×10^4^ into 24 well plates with or without 10 mm glass coverslips. Axenically grown stationary phase *C. burnetii* strains were quantified by qPCR using *dotA* specific primers [@ppat.1004286-Coleman1] and diluted in DMEM with 5% FBS to an MOI of 50. Following a 4 h infection period, cells were washed once with PBS and incubated with fresh DMEM with 5% FBS. This point was considered Day 0 and a sample was collected to provide the inoculum amount of *C. burnetii*. Infection lysate was collected at the time of infection, 24 (Day 1), 72 (Day 3), 120 (Day 5) and 168 (Day 7) h after this initial time point. Genomic DNA was extracted from these samples using the Illustra Bacteria GenomicPrep Mini Prep Kit (GE Healthcare, Piscataway, NJ) and was used to quantify genomic equivalents by *dotA* specific qPCR. In addition, replicate wells were fixed with 4% paraformaldehyde at Day 3 and Day 5 for subsequent immunofluorescent staining with anti-LAMP1 and anti-*C. burnetii* as described above.

BlaM translocation assays {#s4f}
-------------------------

Translocation assays were performed as described previously [@ppat.1004286-Carey1], [@ppat.1004286-Newton1]. Genes of interest were cloned into the *Sal*I site of pJB-CAT-BlaM and these constructs were introduced into *C. burnetii* NMII via electroporation. BlaM fusion protein expression of isolated clones was confirmed by western blot with anti-BlaM (1∶1000), (QED Bioscience Inc, San Diego, CA). 2×10^4^ HeLa cells were plated in black clear bottom 96 well trays and, the following day, were infected with stationary phase *C. burnetii* NMII strains at an MOI of 100. The infection was allowed to proceed for 24 h before cells were loaded with the fluorescent substrate CCF4/AM according to the instructions for the LiveBLAzer-FRET B/G Loading Kit (Invitrogen, Carlsbad, CA). Fluorescence, with an excitation of 415 nm and emission at 460 nm and 535 nm, was quantified using a Tecan M1000 plate reader. The ratio of signal at 460 nm to 535 nm (blue:green) was calculated relative to uninfected cells. In addition, cells were visualized by fluorescence microscopy using an inverted Nikon Eclipse TE-2000 S microscope and a 20× objective.

RNA interference {#s4g}
----------------

In 24-well plates, HeLa229 cells were reverse-transfected with small-interfering RNA (siRNA) SMARTpools specific for human *ATG5* (NM_004849), *ATG12* (NM_004707), *STX17* (NM_017919), or *STX18* (NM_016930) using Dharmafect-1 (Thermo Scientific) at a final concentration of 50 nM total siRNA in DMEM with 5% FBS. Transfected cells were incubated overnight, washed, and the adherent cells were subjected to a second round of siRNA transfection at the same concentration. After a two-day incubation, the cells were infected with *C. burnetii* NMII at a MOI of 50. At one day post-infection, the cells were lifted and replated at a lower cell density into a 24-well plate containing 12-mm-diameter glass coverslips and incubated for an additional two days. Cells were processed for immunofluorescence as described above.

Construction of plasmids encoding RavZ {#s4h}
--------------------------------------

Primers were designed to amplify *ravZ* or *ravZ*C258A from plasmids pGFP-RavZ or pGFP-RavZ~C258A~ [@ppat.1004286-Choy1] by PCR and to contain extended overhangs specific for sequence- and ligation-independent cloning (SLIC) into the pJB-CAT-3×FLAG destination vector [@ppat.1004286-Li1]. The following primers show the destination vector sequence underlined and the *ravZ*-specific sequences italicized: RavZ forward, 5′-[ATATCGATTACAAGGATGACGATGACAAGGTCGAC]{.ul} *ATGAAAGGCAAGTTAACAGG*-3′ and RavZ reverse, 5′-[GGGCGGGGCGTAAAAGCTTGCATGCCTCAGTCGAC]{.ul} *CTATTTTACCTTAATGCCACC*-3′. The resulting vectors pJB-CAT-3×FLAG-RavZ and pJB-CAT-3×FLAG-RavZ~C258A~ encode RavZ proteins that have three tandem copies of the FLAG epitope tag (3×FL) fused to the amino terminus of the protein.

Infection with *C. burnetii* expressing RavZ {#s4i}
--------------------------------------------

Plasmid DNA (pJB-CAT-3×FLAG-RavZ or pJB-CAT-3×FLAG-RavZ C258A) was electroporated into *C. burnetii* NM II, and chloramphenicol-resistant *C. burnetii* were clonally isolated as described previously [@ppat.1004286-Carey1]. Immunoblots of *C. burnetii* lysates using anti-Flag M2 antibody (Sigma) confirmed that 3×FL-RavZ protein was expressed. *C. burnetii* transformed with pJB-CAT-3×FLAG, pJB-CAT-3×FLAG-RavZ or pJB-CAT-3×FLAG-RavZ C258A were used to infect HeLa cells at a MOI of 50. After 10 h incubation, cells were washed and incubated for three days before either fixation with 4% PFA for immunofluorescence, or lysis for immunoblot analysis.

LC3 immunoblot analysis {#s4j}
-----------------------

Uninfected or three-day post-infection *C. burnetii*-infected HeLa cells were lysed as described previously for [Figure 5](#ppat-1004286-g005){ref-type="fig"} [@ppat.1004286-Choy1]. Lysates were centrifuged and the supernatant separated by SDS-PAGE for immunoblot analysis using an anti-LC3 antibody (Novus) at 1∶3000 and an anti-actin antibody (Sigma) at 1∶5000. For [Figure 6](#ppat-1004286-g006){ref-type="fig"}, uninfected or five-day post infection *C. burnetii* infected HeLa cells were maintained in 6-well dishes before harvesting with a cell scraper and lysing in buffer containing 2% Triton-X as described in Tanida *et al.*, 2008 [@ppat.1004286-Tanida1]. Cells were either left untreated prior to lysis, or were incubated in media containing 200 nM rapamycin and 100 ng/ml bafilomycin A1 2 h prior to lysis.

Supporting Information {#s5}
======================

###### 

**The CCVs formed by** ***cig57*** **::Tn and** ***cig2*** **::Tn contain the lysosomal protease cathepsin D.** HeLa 229 cells were infected with *C. burnetii* NMII, *cig2*::Tn or *cig57*:Tn at a multiplicity of 50 bacteria to 1 host cell. At 72 h post-infection the samples were fixed and stained with anti-cathepsin D (green), anti-*Coxiella* (red) and Hoechst dye (blue). Representative images demonstrate that cathepsin D is localized to the CCVs formed by all three strains. Scale bars represent 10 µm.

(PDF)

###### 

Click here for additional data file.

###### 

**Cbu1780 is a novel Dot/Icm effector.** The hypothetical proteins Cbu1780 and Cbu2072 were tested for Dot/Icm-dependent translocation using the β-lactamase translocation assay. *C. burnetii* NMII and the *icmL*::Tn mutant expressing BlaM-1780 or BlaM-2072 from a plasmid were used to infect HeLa cells. At 24 h post-infection, CCF4-AM was incorporated into the cells and translocation was assayed through the quantitative measure of fluorescence at 460 nm and 535 nm (A) and visually (B). Translocation positive cells (blue) were only observed for *C. burnetii* NMII expressing BlaM-1780. [Results](#s2){ref-type="sec"} represent the mean 460::535 nm ratio ± standard deviation from three independent experiments and representative images.

(PDF)

###### 

Click here for additional data file.

###### 

***Coxiella burnetii*** **transposon mutants that do not replicate intracellularly.**

(DOCX)

###### 

Click here for additional data file.

###### 

***Coxiella burnetii*** **transposon mutants that display intracellular replication defects.**

(DOCX)

###### 

Click here for additional data file.

###### 

***Coxiella burnetii*** **transposon mutants with a filamentous phenotype.**

(DOCX)

###### 

Click here for additional data file.

###### 

**Transposon insertions disrupting** ***cbu0021*** **.**

(DOCX)

###### 

Click here for additional data file.

###### 

**Location of transposon insertions in** ***C. burnetii*** **mutants that displayed normal CCV development in the visual screen.**

(DOCX)

###### 

Click here for additional data file.
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